감염 관리 시장 평가 : 유형, 제품, 용도, 최종사용자, 유통 채널, 지역별 기회 및 예측(2017-2031년)

Global infection control market is projected to witness a CAGR of 6.16% during the forecast period 2024-2031F, growing from USD 106.21 billion in 2023 to USD 171.34 billion in 2031F. The market's growth is supported by the escalating threat of multidrug-resistant organisms, rising requirements from the healthcare industry, increasing number of clinical and surgical procedures, and the introduction of stringent guidelines by various regulatory bodies to reduce the threat of acute respiratory diseases.

Increasing healthcare spending is one of the major global infection control market trends. According to the estimates of the American Medical Association, health spending in the United States increased to USD 13,493 per capita or USD 4.4 trillion in 2022. The growing requirement for infection control measures can also be attributed to the increasing stringency in healthcare settings. Due to the rising requirement for surgical interventions and the growing geriatric population, healthcare establishments are adopting stringent cleaning practices, as the weakened immunity of such patients makes them more susceptible to various infections. Thus, this is propelling the demand for robust infection control products and services.

Technological innovations and artificial intelligence are also expected to play a crucial role in supporting the market's growth in the coming years. Innovations such as automated hygiene dispensers, ultraviolet disinfection systems, and robotic cleaners are gaining traction. Advancements and product innovations are expected to aid in streamlining infection control, providing lucrative growth opportunities for the market.

The introduction of infection control programs in various regions across the globe is another major factor boosting global infection control market growth. For instance, the Aryans Institute of Nursing, Rajpura, India, organized a demonstration of infection control and prevention in May 2024 in collaboration with the Homi Bhabha Cancer Hospital, Mullanpur, India. The speakers reflected on the importance of infection control and prevention and elaborated on how the scientific approach supports the prevention of hospital-acquired infections and reduces the threat of microorganisms spreading to healthcare providers, patients, and visitors.

Growing Requirement for Surgical Procedures Boosts Market Demand

The increasing prevalence of different chronic diseases is propelling the requirement for surgical intervention, augmenting the requirement for infection control products and services in various regions across the globe. Surgical site infections account for 20% of hospital-acquired infections, with a pooled prevalence of 2.5-41.9% globally. Due to the heightened requirement for surgical interventions for effective treatment of various health conditions, infection control products and services are increasing as healthcare institutes are increasingly investing in maintaining sterile environments. The rise in the number of minimally invasive surgeries, among other surgical procedures, necessitates the requirement for advanced sterilization processes and services. The growing prioritization of hygiene and cleanliness due to stringent regulations and increasing emphasis on enhancing patient health further augment market demand.

Integration of AI with Infection Control Provides Lucrative Growth Opportunities

The successful integration of artificial intelligence (AI) with infection control will allow medical institutions to recognize the problems they have and determine if artificial intelligence is able to provide an effective solution. AI systems are expected to offload repetitive tasks such as mask compliance auditing and environmental cleaning and offer opportunities for big data analytics of a specific patient group. Over the past years, artificial intelligence has evolved cleaning from manual scrubbing to intelligent robots that have the ability to determine where to focus. With the assistance of artificial intelligence, robots are also able to monitor the air and environment quality in real time and target areas that require additional inputs. Artificial intelligence will also aid professionals in streamlining infection control operations, bolstering the global infection control market size.

North America Accounts for a Significant Share of the Market

The expansion of the market in the region is supported by the strong presence of various market players in North America, the presence of a well-established healthcare infrastructure, and the increasing adoption of infection control technologies due to growing awareness. The rising prevalence of healthcare-associated infections, expansion of the geriatric population, and increasing number of clinics and hospitals are other major factors propelling the demand for infection control in North America. According to the estimates of the Centers for Disease Control, 1.7 million infections and 99,000 associated deaths occur in American hospitals every year. The increased investments by the leading market players towards novel product development and strategic partnerships and collaborations to promote innovations are further boosting the market's growth in North America. The surge in the requirement for surgical procedures due to the rising prevalence of chronic diseases and disorders is another major factor augmenting the demand for infection control products and services.

Demand for Consumable Expected to Witness Significant Increase

The increased demand for consumables can be attributed to the short life cycle and consistent usage of these products. Personal protective equipment is used to provide a barrier between healthcare providers and microorganisms, reducing the risk of exposure. The selection of the products is made after a thorough risk assessment. They should be checked regularly to ensure that their integrity has not been compromised and should be evaluated for the expiration date as well. The segment's growth is boosted by successful collaborations and acquisitions. In May 2024, KARAM Safety acquired Midas Safety India to strengthen their position in personal protective equipment in India.

Additionally, the service segment is also expected to witness significant growth in the coming years. The expansion of the service segment can be attributed to increasing awareness about the availability and benefits of such services and a growing inclination towards reducing expenditures in sectors, including food and beverages, pharmaceutical, biotechnology, and healthcare.

Hospitals Hold Significant Share in the Global Infection Control Market

The increasing construction of hospitals due to rapid population growth and the rising prevalence of chronic health conditions propel the demand for infection control products and services. According to the Delhi Economic Survey, the construction of 11 structural medical facilities, including hospitals, is underway, while various established hospitals are being upgraded. One of the major concerns in hospitals is the risk of infection from drug-resistant bacteria and bloodborne pathogens, among others, in the operating theatre. For instance, the frequent utilization of catheters bolsters the risk of UTIs. Thus, hospitals should be urged to adopt effective infection control equipment and services as they aid in stopping the spread of infections. Infection control is paramount in hospitals, as it helps protect both healthcare workers and patients from diseases.

Future Market Scenario (2024-2031F)

According to the global infection control market analysis, infection control will become the cornerstone of healthcare in the coming years for preventing the transmission of infections across medical settings. The focus on infection control is expected to grow due to the increasing prevalence of hospital-acquired infections and the rising emphasis on patient safety across the globe. Technological advancements and integration of the internet of things and automated systems are further expected to propel the expansion of the infection control market by aiding in optimizing sterilization methods. Innovations in sterilization systems will also aid healthcare professionals in overcoming the various challenges posed by complex and novel medical devices that may require varying sterilization approaches.

Key Players Landscape and Outlook

The major players operating in the global infection control market are 3M, Getinge AB, Steric Plc, Sotera Health, Advanced Sterilization Products, Inc., and MATACHANA GROUP. The expansion of the market is supported by increasing mergers and acquisitions. In October 2023, Medicom Group, one of the leading providers of infection control and prevention solutions, announced the acquisition of Humask portfolio. The transaction also included the intellectual property and technologies developed by the company. This partnership is expected to ensure the availability and continuity of Humask's wide range of innovative protective equipment.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Infection Control Market Outlook, 2017-2031F

• 4.1.Market Size & Forecast
  • 4.1.1.By Value
  • 4.1.2.By Volume
• 4.2.By Type
  • 4.2.1.Services
    • 4.2.1.1.Infectious Waste Disposal
    • 4.2.1.2.Contract Sterilization
      • 4.2.1.2.1.E-Beam Sterilization
      • 4.2.1.2.2.Gamma Sterilization
      • 4.2.1.2.3.Ethylene Oxide Sterilization
      • 4.2.1.2.4.Others
  • 4.2.2.Equipment
    • 4.2.2.1.Sterilization Equipment
      • 4.2.2.1.1.Radiation Sterilization Equipment
      • 4.2.2.1.2.Filtration Sterilization Equipment
      • 4.2.2.1.3.Heat Sterilization Equipment
      • 4.2.2.1.4.Low Temperature Sterilization Equipment
      • 4.2.2.1.5.Liquid Sterilization Equipment
    • 4.2.2.2.Disinfectors
      • 4.2.2.2.1.Washers
      • 4.2.2.2.2.Endoscope Reprocessors
      • 4.2.2.2.3.Flushes
    • 4.2.2.3.Others
  • 4.2.3.Consumables
    • 4.2.3.1.Sterilization Consumables
    • 4.2.3.2.Disinfectants
    • 4.2.3.3.Personal Protective Equipment
    • 4.2.3.4.Others
• 4.3.By Product
  • 4.3.1.Sterilization Products
  • 4.3.2.Cleaning and Disinfection Products
  • 4.3.3.Personal Protective Barriers
  • 4.3.4.Endoscope Reprocessing Products
  • 4.3.5.Anti-Microbial Surfaces
  • 4.3.6.Other Infection Control Products
• 4.4.By Application
  • 4.4.1.Surgical Instruments
  • 4.4.2.Endoscopes
  • 4.4.3.Ultrasound Probes
  • 4.4.4.Others
• 4.5.By End-user
  • 4.5.1.Hospitals
  • 4.5.2.Clinics
  • 4.5.3.Diagnostic Laboratories
  • 4.5.4.Medical Device Companies
  • 4.5.5.Biotechnology and Pharmaceutical Companies
  • 4.5.6.Others
• 4.6.By Distribution Channel
  • 4.6.1.Retail Sales
  • 4.6.2.Third Party Distributors
  • 4.6.3.Direct Tender
• 4.7.By Region
  • 4.7.1.North America
  • 4.7.2.South America
  • 4.7.3.Europe
  • 4.7.4.Asia-Pacific
  • 4.7.5.Middle East and Africa
• 4.8.By Company Market Share (%), 2023

5.Global Infection Control Market Outlook, By Region, 2017-2031F

• 5.1.North America*
  • 5.1.1.Market Size & Forecast
    • 5.1.1.1.By Value
    • 5.1.1.2.By Volume
  • 5.1.2.By Type
    • 5.1.2.1.Services
      • 5.1.2.1.1.Infectious Waste Disposal
      • 5.1.2.1.2.Contract Sterilization
        • 5.1.2.1.2.1.E-Beam Sterilization
        • 5.1.2.1.2.2.Gamma Sterilization
        • 5.1.2.1.2.3.Ethylene Oxide Sterilization
        • 5.1.2.1.2.4.Others
    • 5.1.2.2.Equipment
      • 5.1.2.2.1.Sterilization Equipment
        • 5.1.2.2.1.1.Radiation Sterilization Equipment
        • 5.1.2.2.1.2.Filtration Sterilization Equipment
        • 5.1.2.2.1.3.Heat Sterilization Equipment
        • 5.1.2.2.1.4.Low Temperature Sterilization Equipment
        • 5.1.2.2.1.5.Liquid Sterilization Equipment
      • 5.1.2.2.2.Disinfectors
        • 5.1.2.2.2.1.Washers
        • 5.1.2.2.2.2.Endoscope Reprocessors
        • 5.1.2.2.2.3.Flushes
      • 5.1.2.2.3.Others
    • 5.1.2.3.Consumables
      • 5.1.2.3.1.Sterilization Consumables
      • 5.1.2.3.2.Disinfectants
      • 5.1.2.3.3.Personal Protective Equipment
      • 5.1.2.3.4.Others
  • 5.1.3.By Product
    • 5.1.3.1.Sterilization Products
    • 5.1.3.2.Cleaning and Disinfection Products
    • 5.1.3.3.Personal Protective Barriers
    • 5.1.3.4.Endoscope Reprocessing Products
    • 5.1.3.5.Anti-Microbial Surfaces
    • 5.1.3.6.Other Infection Control Products
  • 5.1.4.By Application
    • 5.1.4.1.Surgical Instruments
    • 5.1.4.2.Endoscopes
    • 5.1.4.3.Ultrasound Probes
    • 5.1.4.4.Others
  • 5.1.5.By End-user
    • 5.1.5.1.Hospitals
    • 5.1.5.2.Clinics
    • 5.1.5.3.Diagnostic Laboratories
    • 5.1.5.4.Medical Device Companies
    • 5.1.5.5.Biotechnology and Pharmaceutical Companies
    • 5.1.5.6.Others
  • 5.1.6.By Distribution Channel
    • 5.1.6.1.Retail Sales
    • 5.1.6.2.Third Party Distributors
    • 5.1.6.3.Direct Tender
  • 5.1.7.United States*
    • 5.1.7.1.Market Size & Forecast
      • 5.1.7.1.1.By Value
      • 5.1.7.1.2.By Volume
    • 5.1.7.2.By Type
      • 5.1.7.2.1.Services
        • 5.1.7.2.1.1.Infectious Waste Disposal
        • 5.1.7.2.1.2.Contract Sterilization
        • 5.1.7.2.1.2.1.E-Beam Sterilization
        • 5.1.7.2.1.2.2.Gamma Sterilization
        • 5.1.7.2.1.2.3.Ethylene Oxide Sterilization
        • 5.1.7.2.1.2.4.Others
      • 5.1.7.2.2.Equipment
        • 5.1.7.2.2.1.Sterilization Equipment
        • 5.1.7.2.2.1.1.Radiation Sterilization Equipment
        • 5.1.7.2.2.1.2.Filtration Sterilization Equipment
        • 5.1.7.2.2.1.3.Heat Sterilization Equipment
        • 5.1.7.2.2.1.4.Low Temperature Sterilization Equipment
        • 5.1.7.2.2.1.5.Liquid Sterilization Equipment
        • 5.1.7.2.2.2.Disinfectors
        • 5.1.7.2.2.2.1.Washers
        • 5.1.7.2.2.2.2.Endoscope Reprocessors
        • 5.1.7.2.2.2.3.Flushes
        • 5.1.7.2.2.3.Others
      • 5.1.7.2.3.Consumables
        • 5.1.7.2.3.1.Sterilization Consumables
        • 5.1.7.2.3.2.Disinfectants
        • 5.1.7.2.3.3.Personal Protective Equipment
        • 5.1.7.2.3.4.Others
    • 5.1.7.3.By Product
      • 5.1.7.3.1.Sterilization Products
      • 5.1.7.3.2.Cleaning and Disinfection Products
      • 5.1.7.3.3.Personal Protective Barriers
      • 5.1.7.3.4.Endoscope Reprocessing Products
      • 5.1.7.3.5.Anti-Microbial Surfaces
      • 5.1.7.3.6.Other Infection Control Products
    • 5.1.7.4.By Application
      • 5.1.7.4.1.Surgical Instruments
      • 5.1.7.4.2.Endoscopes
      • 5.1.7.4.3.Ultrasound Probes
      • 5.1.7.4.4.Others
    • 5.1.7.5.By End-user
      • 5.1.7.5.1.Hospitals
      • 5.1.7.5.2.Clinics
      • 5.1.7.5.3.Diagnostic Laboratories
      • 5.1.7.5.4.Medical Device Companies
      • 5.1.7.5.5.Biotechnology and Pharmaceutical Companies
      • 5.1.7.5.6.Others
    • 5.1.7.6.By Distribution Channel
      • 5.1.7.6.1.Retail Sales
      • 5.1.7.6.2.Third Party Distributors
      • 5.1.7.6.3.Direct Tender
  • 5.1.8.Canada
  • 5.1.9.Mexico

All segments will be provided for all regions and countries covered

• 5.2.Europe
  • 5.2.1.Germany
  • 5.2.2.France
  • 5.2.3.Italy
  • 5.2.4.United Kingdom
  • 5.2.5.Russia
  • 5.2.6.Netherlands
  • 5.2.7.Spain
  • 5.2.8.Turkey
  • 5.2.9.Poland
• 5.3.Asia-Pacific
  • 5.3.1.India
  • 5.3.2.China
  • 5.3.3.Japan
  • 5.3.4.Australia
  • 5.3.5.Vietnam
  • 5.3.6.South Korea
  • 5.3.7.Indonesia
  • 5.3.8.Philippines
• 5.4.South America
  • 5.4.1.Brazil
  • 5.4.2.Argentina
• 5.5.Middle East and Africa
  • 5.5.1.Saudi Arabia
  • 5.5.2.UAE
  • 5.5.3.South Africa

6.Market Mapping, 2023

• 6.1.By Type
• 6.2.By Product
• 6.3.By Application
• 6.4.By End-user
• 6.5.By Distribution Channel
• 6.6.By Region

7.Macro Environment and Industry Structure

• 7.1.Supply Demand Analysis
• 7.2.Import Export Analysis
• 7.3.Value Chain Analysis
• 7.4.PESTEL Analysis
  • 7.4.1.Political Factors
  • 7.4.2.Economic System
  • 7.4.3.Social Implications
  • 7.4.4.Technological Advancements
  • 7.4.5.Environmental Impacts
  • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5.Porter's Five Forces Analysis
  • 7.5.1.Supplier Power
  • 7.5.2.Buyer Power
  • 7.5.3.Substitution Threat
  • 7.5.4.Threat From New Entrant
  • 7.5.5.Competitive Rivalry

8.Market Dynamics

• 8.1.Growth Drivers
• 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

• 9.1.Patent Landscape
• 9.2.Regulatory Approvals
• 9.3.Innovations/Emerging Technologies

10.Key Players Landscape

• 10.1.Competition Matrix of Top Five Market Leaders
• 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
• 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4.SWOT Analysis (For Five Market Players)
• 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

• 13.1.3M Company
  • 13.1.1.Company Details
  • 13.1.2.Key Management Personnel
  • 13.1.3.Products and Services
  • 13.1.4.Financials (As reported)
  • 13.1.5.Key Market Focus and Geographical Presence
  • 13.1.6.Recent Developments
• 13.2.Getinge AB
• 13.3.Steric Plc
• 13.4.Sotera Health
• 13.5.Advanced Sterilization Products, Inc.
• 13.6.MATACHANA GROUP
• 13.7.MMM Group
• 13.8.Belimed AG
• 13.9.Halyard Health (Owens & Minor, Inc.)
• 13.10.Ecolab Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14.Strategic Recommendations

15.About Us & Disclaimer